Oncotelic Therapeutics
(OTCQB:OTLC)
$0.036
-0.0034[-8.63%]
At close: Apr 23

Oncotelic Therapeutics Stock (OTC:OTLC), Analyst Ratings, Price Targets, Predictions

Analysts publish ratings and price targets on most stocks. Benzinga tracks 120 analyst firms so investors can understand if analysts expect a stock to trade higher or lower. Ratings are directional and typically buy, sell or hold. Price Targets are an analyst's best guess at where the stock will trade in 12 months.

Analyst Ratings for Oncotelic Therapeutics

No data available to display
date
ticker
Buy Now
Company
Current price
Upside/Downside
Analyst Firm
Analyst & % Accurate
Price Target Change
Rating Change
Previous / Current Rating
Get Alert

FAQ

Q

What is the target price for Oncotelic Therapeutics (OTLC)?

A

There is no price target for Oncotelic Therapeutics.

Q

What is the most recent analyst rating for Oncotelic Therapeutics (OTLC)?

A

There is no analyst for Oncotelic Therapeutics.

Q

When was the last upgrade for Oncotelic Therapeutics (OTLC)?

A

There is no last upgrade for Oncotelic Therapeutics.

Q

When was the last downgrade for Oncotelic Therapeutics (OTLC)?

A

There is no last downgrade for Oncotelic Therapeutics.

Q

When is the next analyst rating going to be posted or updated for Oncotelic Therapeutics (OTLC)?

A

There is no next analyst rating for Oncotelic Therapeutics.

Q

Is the Analyst Rating Oncotelic Therapeutics (OTLC) correct?

A

There is no next analyst rating for Oncotelic Therapeutics.

Browse analyst ratings and price targets on all stocks.